Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?

Pettit L, Meade S, Sanghera P, Glaholm J, Geh JI, Hartley A.

Br J Radiol. 2013 Jan;86(1021):20120372. doi: 10.1259/bjr.20120372.

2.

Revised radiobiological modelling of the contribution of synchronous chemotherapy to the rate of grades 3-4 mucositis in head and neck cancer.

Meade S, McConkey C, Sanghera P, Mehanna H, Hartley A.

J Med Imaging Radiat Oncol. 2013 Dec;57(6):733-8; quiz 739-40. doi: 10.1111/1754-9485.12096. Epub 2013 Jul 9.

PMID:
24283564
3.

Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancer.

Meade S, Sanghera P, Glaholm J, Hartley A.

Tumour Biol. 2014 Mar;35(3):2017-23. doi: 10.1007/s13277-013-1267-0. Epub 2013 Oct 9.

PMID:
24104502
4.

Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck.

Hartley A, Sanghera P, Glaholm J, Mehanna H, McConkey C, Fowler J.

Clin Oncol (R Coll Radiol). 2010 Mar;22(2):125-30. doi: 10.1016/j.clon.2009.10.004. Epub 2009 Oct 31.

PMID:
19880297
5.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
6.

[Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].

Troussier I, Huguet F, Servagi-Vernat S, Benahim C, Khalifa J, Darmon I, Ortholan C, Krebs L, Dejean C, Fenoglietto P, Vieillot S, Bensadoun RJ, Thariat J.

Cancer Radiother. 2015 Apr;19(2):127-38. doi: 10.1016/j.canrad.2014.12.005. Epub 2015 Mar 12. French.

PMID:
25770884
7.

Altered fractionation outcomes for hypoxic head and neck cancer using the HYP-RT Monte Carlo model.

Harriss-Phillips WM, Bezak E, Yeoh EK.

Br J Radiol. 2013 Apr;86(1024):20120443. doi: 10.1259/bjr.20120443. Epub 2013 Feb 7.

8.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
9.

Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.

Meade S, Sanghera P, McConkey C, Fowler J, Fountzilas G, Glaholm J, Hartley A.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):157-63. doi: 10.1016/j.ijrobp.2012.11.023. Epub 2013 Jan 17.

PMID:
23332227
10.

[Results of complex treatment of patients with squamous cell carcinoma of the anal canal using advanced radiotherapy technologies].

Glebovskaya VV, Tkachev SI, Rasulov AO, Tsaryuk VF, Gordeev SS, Fedyanin MY, Aliev VA, Mamedly ZZ, Kuzmichev DV, Trofimova OP, Borisova TN, Yazhgunovich IP.

Vopr Onkol. 2015;61(4):656-60. Russian.

PMID:
26571840
11.

[Radiotherapy for anal canal cancers].

Peiffert D, Créhange G, Vendrely V, Baumann AS, Faivre JC, Huger S.

Cancer Radiother. 2016 Sep;20 Suppl:S183-8. doi: 10.1016/j.canrad.2016.07.061. Epub 2016 Aug 11. French.

PMID:
27523411
12.

Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.

Portaluri M, Fucilli FI, Castagna R, Bambace S, Pili G, Tramacere F, Russo D, Francavilla MC.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1036-43. Epub 2006 Jun 5.

PMID:
16750321
13.

Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.

Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A, Agrawal JP.

Head Neck. 2014 Nov;36(11):1573-80. doi: 10.1002/hed.23482. Epub 2014 Mar 17.

PMID:
23996654
14.

Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.

Cvek J, Kubes J, Skacelikova E, Otahal B, Kominek P, Halamka M, Feltl D.

Strahlenther Onkol. 2012 Aug;188(8):666-70. doi: 10.1007/s00066-012-0128-x. Epub 2012 Jun 1.

PMID:
22648405
15.

Evaluation of a 36 Gy elective node irradiation dose in anal cancer.

Lépinoy A, Lescut N, Puyraveau M, Caubet M, Boustani J, Lakkis Z, Fantoli M, Buffet-Miny J, Kim S, Bednarek C, Maingon P, Créhange G, Bosset JF.

Radiother Oncol. 2015 Aug;116(2):197-201. doi: 10.1016/j.radonc.2015.07.050. Epub 2015 Aug 12.

PMID:
26277433
16.

Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.

Rodriguez CP, Adelstein DJ, Rybicki LA, Savvides P, Saxton JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI.

Head Neck. 2015 Nov;37(11):1583-9. doi: 10.1002/hed.23794. Epub 2014 Oct 29.

PMID:
24909549
17.

[Brachytherapy for anal cancers].

Pommier P, Mirabel X, Hannoun-Lévi JM, Malet C, Gérard JP, Peiffert D.

Cancer Radiother. 2013 Apr;17(2):143-50. doi: 10.1016/j.canrad.2013.02.006. Epub 2013 Apr 11. Review. French.

PMID:
23582604
18.

IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.

Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e845-52. doi: 10.1016/j.ijrobp.2010.10.021. Epub 2010 Dec 16.

PMID:
21167654
19.

A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.

Varveris H, Mazonakis M, Vlachaki M, Kachris S, Lyraraki E, Zoras O, Maris T, Froudarakis M, Velegrakis J, Perysinakis C, Damilakis J, Samonis G.

Oncol Rep. 2003 Jan-Feb;10(1):185-95.

PMID:
12469168
20.

Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?

Henkenberens C, Meinecke D, Michael S, Bremer M, Christiansen H.

Strahlenther Onkol. 2015 Nov;191(11):845-54. doi: 10.1007/s00066-015-0885-4. Epub 2015 Aug 26.

PMID:
26307627

Supplemental Content

Support Center